105.64

5.18% 4.87

Rhythm Pharmaceuticals Inc (RYTM)

Overview News Price History Option Chain Financials Discussions Forecast

Rhythm Pharmaceuticals Inc stock is traded at $105.64, with a volume of 221.53K. It is up +5.18% in the last 24 hours and up +10.15% over the past month. Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

Previous Close:

$100.77

Open:

$100.46

24h Volume:

221.53K

Relative Volume:

0.38

Market Cap:

$7.02B

Revenue:

$136.86M

Net Income/Loss:

$-168.69M

P/E Ratio:

-37.59

EPS:

-2.81

Net Cash Flow:

$-113.49M

1W Performance:

+6.17%

1M Performance:

+10.15%

6M Performance:

+76.24%

1Y Performance:

+110.97%

1-Day Range:

$100.14

$106.13

1-Week Range:

$97.97

$106.13

52-Week Range:

$45.91

$106.52

Rhythm Pharmaceuticals Inc Stock (RYTM) Company Profile

Name

Rhythm Pharmaceuticals Inc

Sector

Healthcare (1146)

Industry

Biotechnology (639)

Phone

857-264-4280

Address

222 BERKELEY STREET, BOSTON, MA

Employee

283

Twitter

@rhythmpharma

Next Earnings Date

2024-11-05

Latest SEC Filings

RYTM's Discussions on Twitter

Compare RYTM with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
RYTM Rhythm Pharmaceuticals Inc	105.69	6.70B	136.86M	-168.69M	-113.49M	-2.81
VRTX Vertex Pharmaceuticals Inc	409.23	104.55B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	473.37	60.36B	2.46B	-319.09M	-52.09M	-2.4669
REGN Regeneron Pharmaceuticals Inc	560.78	59.84B	14.21B	4.46B	3.56B	39.69
ARGX Argen X Se Adr	795.60	49.07B	3.06B	1.28B	447.35M	19.67
ONC Beone Medicines Ltd Adr	321.00	35.16B	4.56B	-176.77M	225.30M	-1.7177

Rhythm Pharmaceuticals Inc Stock (RYTM) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-10-25	Initiated	Goldman	Buy
Jul-07-25	Initiated	Leerink Partners	Outperform
Apr-07-25	Upgrade	BofA Securities	Neutral → Buy
Mar-05-25	Resumed	Stifel	Buy
Jan-02-25	Initiated	Jefferies	Buy
Dec-20-24	Initiated	Oppenheimer	Outperform
Oct-21-24	Initiated	Guggenheim	Buy
Sep-18-24	Initiated	H.C. Wainwright	Buy
Sep-17-24	Initiated	JMP Securities	Mkt Outperform
May-08-24	Downgrade	BofA Securities	Buy → Neutral
Dec-19-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Aug-01-23	Upgrade	BofA Securities	Neutral → Buy
Jan-18-23	Resumed	Canaccord Genuity	Buy
Aug-08-22	Upgrade	Goldman	Neutral → Buy
Aug-05-22	Upgrade	BofA Securities	Underperform → Neutral
Jun-17-22	Reiterated	Needham	Buy
Mar-02-22	Resumed	Stifel	Buy
Feb-17-22	Upgrade	Ladenburg Thalmann	Neutral → Buy
Dec-08-21	Initiated	Wells Fargo	Overweight
Nov-19-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Sep-14-21	Resumed	Goldman	Neutral
Aug-04-21	Downgrade	BofA Securities	Neutral → Underperform
Aug-04-21	Downgrade	Ladenburg Thalmann	Buy → Neutral
Nov-30-20	Downgrade	BofA Securities	Buy → Neutral
Jan-08-20	Initiated	Goldman	Sell
Jul-12-19	Upgrade	Stifel	Hold → Buy
Jul-08-19	Initiated	Canaccord Genuity	Buy
Mar-13-19	Initiated	Ladenburg Thalmann	Buy
Sep-07-18	Resumed	Morgan Stanley	Overweight
Jun-25-18	Reiterated	Needham	Buy
Jun-15-18	Reiterated	Needham	Buy
Oct-30-17	Initiated	BofA/Merrill	Buy
Oct-30-17	Initiated	Needham	Buy

View All

Rhythm Pharmaceuticals Inc Stock (RYTM) Latest News

06:00 AM

Is it too late to sell Rhythm Pharmaceuticals Inc.Trade Entry Report & Long-Term Investment Growth Plans - newser.com

06:00 AM

04:11 AM

Is a relief rally coming for Rhythm Pharmaceuticals Inc. holdersJuly 2025 Review & Capital Efficiency Focused Strategies - newser.com

04:11 AM

Oct 13, 2025

Is Rhythm Pharmaceuticals Inc. trending in predictive chart modelsTrade Volume Summary & Fast Entry and Exit Trade Plans - newser.com

Oct 13, 2025

Rhythm Pharmaceuticals Inc. stock trend forecastJuly 2025 Technicals & Low Risk Entry Point Guides - newser.com

Oct 13, 2025

Is Rhythm Pharmaceuticals Inc. reversing from oversold territory2025 Key Lessons & AI Driven Price Predictions - newser.com

Oct 13, 2025

Using RSI to spot recovery in Rhythm Pharmaceuticals Inc.July 2025 Fed Impact & AI Based Buy and Sell Signals - newser.com

Oct 13, 2025

Is Rhythm Pharmaceuticals Inc. (1RV) stock supported by free cash flowWeekly Market Report & Safe Entry Point Identification - newser.com

Oct 13, 2025

Is Rhythm Pharmaceuticals Inc. stock dividend yield sustainablePortfolio Value Summary & High Yield Stock Recommendations - newser.com

Oct 13, 2025

Rhythm Pharmaceuticals (RYTM) Stock Analysis: A Biotech Powerhouse with 17% Upside Potential - DirectorsTalk Interviews

Oct 13, 2025

Oct 12, 2025

Long term hold vs stop loss in Rhythm Pharmaceuticals Inc.July 2025 Big Picture & Safe Entry Momentum Tips - newser.com

Oct 12, 2025

Oct 10, 2025

What analysts say about Rhythm Pharmaceuticals Inc 1RV stockVolatility Index Analysis & Minimize Portfolio Damage with Warnings - earlytimes.in

Oct 10, 2025

Should you hold or exit Rhythm Pharmaceuticals Inc. now2025 Top Gainers & Trade Opportunity Analysis - newser.com

Oct 10, 2025

What indicators show strength in Rhythm Pharmaceuticals Inc.Weekly Profit Recap & Capital Efficiency Focused Ideas - newser.com

Oct 10, 2025

Leo Wealth LLC Has $850,000 Stock Holdings in Rhythm Pharmaceuticals, Inc. $RYTM - MarketBeat

Oct 10, 2025

Is Rhythm Pharmaceuticals Inc. (1RV) stock a safe buy pre earningsCEO Change & Consistent Growth Equity Picks - newser.com

Oct 10, 2025

Oct 09, 2025

Rhythm Pharma Stock Gears Up For Its Next Move - inkl

Oct 09, 2025

How to recover losses in Rhythm Pharmaceuticals Inc. stock2025 Market Outlook & Fast Exit and Entry Strategy Plans - newser.com

Oct 09, 2025

Rhythm Pharmaceuticals (NASDAQ:RYTM) Receives "Sell (D-)" Rating from Weiss Ratings - MarketBeat

Oct 09, 2025

Is Rhythm Pharmaceuticals Inc. meeting your algorithmic filter criteria2025 Key Lessons & Low Risk High Win Rate Stock Picks - newser.com

Oct 09, 2025

Why Rhythm Pharmaceuticals Inc. (1RV) stock could be next leaderWeekly Loss Report & Free Weekly Chart Analysis and Trade Guides - newser.com

Oct 09, 2025

Oct 07, 2025

Is Rhythm Pharmaceuticals Inc a good long term investmentEconomic Indicators Overview & Low Risk Capital Growth Plans - earlytimes.in

Oct 07, 2025

Oct 06, 2025

What momentum shifts mean for Rhythm Pharmaceuticals Inc.July 2025 Reactions & Weekly Hot Stock Watchlists - newser.com

Oct 06, 2025

Rhythm Pharmaceuticals (RYTM) Stock Analysis: A Biotech Giant with 19.53% Potential Upside - DirectorsTalk Interviews

Oct 06, 2025

Will Rhythm Pharmaceuticals Inc. rebound enough to break evenRecession Risk & Verified High Yield Trade Plans - newser.com

Oct 06, 2025

Oct 05, 2025

Using data tools to time your Rhythm Pharmaceuticals Inc. exitJuly 2025 Macro Moves & Intraday High Probability Alerts - newser.com

Oct 05, 2025

Is Rhythm Pharmaceuticals Inc. stock cheap at current valuationWeekly Trading Summary & Weekly Stock Breakout Alerts - newser.com

Oct 05, 2025

Institutional scanner results for Rhythm Pharmaceuticals Inc.Market Volume Report & Fast Exit/Entry Strategy Plans - newser.com

Oct 05, 2025

Oct 03, 2025

Should You Expect Robust Growth Potential for Rhythm Pharmaceuticals (RYTM) Ahead? - Yahoo Finance

Oct 03, 2025

Oct 02, 2025

Is Rhythm Pharmaceuticals Inc. (1RV) stock a buy before earnings resultsJuly 2025 News Drivers & Intraday High Probability Setup Alerts - newser.com

Oct 02, 2025

Sep 30, 2025